SAN DIEGO, Feb. 29, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, March 7, 2012 at 10:40am Eastern Time (7:40am Pacific Time) during the Cowen and Company 32nd Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston.
The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV® (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S. For more information about Cadence, please visit www.cadencepharm.com.Contacts:
William R. LaRue
Cadence Pharmaceuticals, Inc.
|SOURCE Cadence Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved